Clinical Trials Logo

Clinical Trial Summary

Develop and evaluate the effectiveness of multi-level participatory interventions in reducing arsenic exposure among American Indian (AI) communities from North and South Dakota who participated in the Strong Heart Study (SHS).


Clinical Trial Description

Design, implement, and evaluate multi-level participatory interventions that can lead to a sustained reduction in arsenic exposure in adults and children in Cheyenne River, Oglala, and Spirit Lake communities in North/South Dakota by: 1) building local capacity at the tribal and community levels to ensure the long-term sustainability of the interventions. 2) conduct a 2-arm cluster-randomized controlled trial comparing arsenic removal device only to removal device and intensive education and promotion among 300 households, 600 participants. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03725592
Study type Interventional
Source Johns Hopkins Bloomberg School of Public Health
Contact
Status Active, not recruiting
Phase N/A
Start date July 2, 2018
Completion date May 4, 2024

See also
  Status Clinical Trial Phase
Completed NCT02429921 - High-selenium Lentils Versus Arsenic Toxicity N/A
Active, not recruiting NCT02235948 - Effects of Folic Acid Supplementation on Arsenic Lowering Phase 2
Completed NCT01442727 - Selenium in the Treatment of Arsenic Toxicity and Cancers Phase 3